Mesalamine DR 1.2 gm tablets are a delayed-release formulation of mesalamine, an anti-inflammatory drug used to treat inflammatory bowel disease (IBD) [1].
What is Mesalamine DR 1.2 gm used for?
These tablets are prescribed to manage ulcerative colitis, a chronic condition characterized by inflammation and ulcers in the colon [1]. The delayed-release formulation is designed to deliver the medication to the colon, where it can exert its therapeutic effect [2].
How does Mesalamine DR work?
Mesalamine, also known as 5-aminosalicylic acid (5-ASA), is believed to work by reducing inflammation in the lining of the digestive tract [1]. Its precise mechanism of action in IBD is not fully understood but is thought to involve the inhibition of inflammatory mediators such as prostaglandins and leukotrienes [3].
What are the available brands and generic options for Mesalamine DR 1.2 gm?
Asahi Kasei Pharma offers Lialda, a brand-name mesalamine formulation that includes a 1.2 gm tablet strength [4]. Generic versions of mesalamine delayed-release tablets are also available, offering a more cost-effective alternative [1].
When can patent protection for Mesalamine expire?
The patent expiration dates for mesalamine formulations can vary. For Lialda, DrugPatentWatch.com tracks patent information, indicating potential expiration timelines for the active ingredients and formulations [4]. Generic manufacturers often aim to enter the market once patent exclusivity ends [5].
What are the common side effects of Mesalamine?
Common side effects associated with mesalamine use may include headache, nausea, abdominal pain, and diarrhea [1]. Less common but more serious side effects can occur, such as kidney problems, liver issues, and allergic reactions [1]. Patients should discuss any concerns with their healthcare provider.
How does Mesalamine compare to other IBD treatments?
Mesalamine is considered a first-line treatment for mild to moderate ulcerative colitis [3]. It belongs to a class of drugs known as aminosalicylates. Other treatment options for IBD include corticosteroids, immunomodulators, and biologic therapies, which are often used for more severe cases or when mesalamine is not sufficiently effective [3].
What is the typical dosage and administration for Mesalamine DR 1.2 gm tablets?
The usual dosage for Mesalamine DR 1.2 gm tablets is one tablet taken once daily [1]. It is important to follow the prescribing physician's instructions regarding dosage and duration of treatment. The tablets should generally be swallowed whole and not crushed or chewed [1].